News Headlines Article

Cuban-Developed Lung Cancer Vaccine Could Arrive in US
ABC News

As U.S. relations with Cuba thaw, one unexpected byproduct could be the introduction of a Cuban-developed lung cancer vaccine in the U.S. called Cimavax, an innovative vaccine that was developed to help treat lung cancer patients in Cuba, where lung cancer is one of the leading causes of death.

The immunotherapy treatment could be coming to the U.S. thanks in part to the Roswell Park Cancer Institute in Buffalo, New York, which is working with Cuba’s Center for Molecular Immunology to bring the treatment to the U.S.

Commands